News Releases

Anixa Biosciences and OntoChem Enter Next Stage of Development for Covid-19 Therapeutic

April 5, 2021

Anixa Biosciences Increases Previously Announced Bought Deal Offering of Common Stock to $22.5 Million

March 22, 2021

Anixa Biosciences Announces $10 Million Bought Deal Offering of Common Stock

March 22, 2021

Anixa Biosciences and Moffitt Cancer Center File IND Application for Ovarian Cancer CAR-T Therapy

March 22, 2021

Anixa Biosciences Announces Issuance and Publication of European Patent for Ovarian Cancer Vaccine Technology

March 12, 2021

Anixa Biosciences to Participate in M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference

March 8, 2021

Anixa Biosciences Announces European Patent Issued for its CAR-T Cancer Therapy

March 4, 2021

Anixa Biosciences to Present at the H.C. Wainwright Global Life Sciences Conference

February 25, 2021

Anixa Biosciences Begins Animal Testing of Covid-19 Therapeutic Candidates

February 16, 2021

Anixa Biosciences to Present at the B. Riley Oncology Investor Conference

January 13, 2021

1
2
3
4
5
6
7
8
9
10
...17
Next »

Latest News & Events

Apr 5, 2021

Anixa Biosciences and OntoChem Enter Next Stage of Development for Covid-19 Therapeutic

Read More...

Mar 22, 2021

Anixa Biosciences Increases Previously Announced Bought Deal Offering of Common Stock to $22.5 Million

Read More...

Mar 22, 2021

Anixa Biosciences Announces $10 Million Bought Deal Offering of Common Stock

Read More...